🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Metastatic Thyroid Cancer

Preoperative Prediction of Lymph Node Metastasis in T1N0M0 Papillary Thyroid Carcinoma by Using Contrast-enhanced Ultrasound NCT07357571n/a2 sites📍 Guangdong📍 Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University MRG003 and Pucotenlimab to Treat Locally Advanced or Metastatic ATC/PDTC NCT07235566Phase 21 site📍 Shanghai Fudan University · Tests: MRG003 in combination with pucotenlimab Safety and Efficacy of Recombinant Human Thyroid Stimulating Hormone for Adjuvant Diagnosis in Patients With Locally Advanced/Metastatic Differentiated Thyroid Cancer NCT06431620NA1 site📍 Nanjing Nanjing First Hospital, Nanjing Medical University · Tests: Recombinant Human Thyroid Stimulating Hormone Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma NCT03647358Phase 11 site📍 New York Memorial Sloan Kettering Cancer Center · Tests: PET/CT Scan, Iodine-124 Selective Neck Dissection Versus Modified Neck Dissection in PTC NCT06554652Phase 31 site📍 Shanghai Fudan University · Tests: Lymph node tracer navigated selective neck dissection, Modified neck dissection New MRI Biomarkers in Head and Neck Cancers NCT03483337n/a1 site📍 New York Memorial Sloan Kettering Cancer Center · Tests: MRI examinations, MRI examinations Integrated Cancer Repository for Cancer Research NCT02012699n/a42 sites📍 Greenwood Village📍 Manchester📍 Daytona Beach University of Nebraska Comparative Study of Transaxillary Robotic Thyroidectomy With MRND Versus Conventional Open Surgery in N1b PTC NCT06623578NA1 site📍 Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Tests: robotic-assisted surgery, Open Surgery Sacituzumab Govitecan in Metastatic Salivary Gland and Thyroid Cancers (SG-SGTC) NCT06923826Phase 21 site📍 Singapore National University Hospital, Singapore · Tests: Sacituzumab govitecan Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial NCT04693377NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: Cryosurgery, Quality-of-Life Assessment, Stereotactic Body Radiation Therapy Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies NCT05786924Phase 1, Phase 249 sites📍 Gilbert📍 Los Angeles📍 Los Angeles Institut de Recherches Internationales Servier · Tests: S241656, FOLFOX6/FOLFOX7, FOLFIRI, Cetuximab, Panitumumab Phase II Trial of Tunlametinib in NRAS-Mutant Advanced Thyroid Cancer NCT06970353Phase 21 site📍 Shanghai Fudan University · Tests: Tunlametinib, Tunlametinib+PD-1 mAb Lateral Cervical Node Dissection in Differentiated Thyroid Cancer. NCT06149637NA1 site📍 Medellín Centro de Excelencia en Enfermedades de Cabeza y Cuello · Tests: Traditional neck dissection approach, Anterior neck dissection approach Pralsetinib DDI Study in Patients With Advanced or Metastatic Solid Tumors NCT07704658Phase 42 sites📍 Logroño📍 Madrid Rigel Pharmaceuticals · Tests: Pralsetinib, CYP3A4, CYP2C8, and CYP2C9 substrates, and hormonal contraceptive Trophoblast Cell-Surface Antigen 2 (Trop-2) Targeted PET/CT in Recurrent and Metastatic Thyroid Cancer NCT07753499NA1 site📍 Xiamen The First Affiliated Hospital of Xiamen University · Tests: Compared the diagnostic performance of 68Ga-MY6349 PET/CT with 68Ga-FAPI PET/CT Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer NCT06359847Phase 21 site📍 Beijing Beijing Scitech-Mq Pharmaceuticals Limited · Tests: ST-1898 tablets Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer NCT03099356Phase 21 site📍 Ann Arbor University of Michigan Rogel Cancer Center · Tests: Cyclophosphamide, Sirolimus XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer NCT06959641Phase 22 sites📍 Torrance📍 Chicago Jochen Lorch · Tests: Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Survey Administration, X-Ray Imaging Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I Treatment NCT06405217NA1 site📍 Nanjing Nanjing First Hospital, Nanjing Medical University · Tests: Recombinant Human Thyroid Stimulating Hormone Irreversible Electroporation for Recurrent or Metastatic Cervical Lymph Node Metastases From Thyroid Cancer: A Prospective Multicenter Single-Arm Study NCT07328243NA3 sites📍 Guangzhou📍 Hangzhou📍 Hangzhou Tian'an Jiang · Tests: Irreversible Electroporation (IRE) Ablation Oropharynx (OPX) Biomarker Trial NCT06356272n/a1 site📍 Rochester Mayo Clinic · Tests: Non-Interventional Study Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC NCT05668962Phase 26 sites📍 Washington D.C.📍 Tampa📍 Boston Massachusetts General Hospital · Tests: Selpercatinib, Sodium Iodine I-131, rhTSH The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer NCT04927416Phase 21 site📍 Bethesda National Institute of Diabetes and Digestive and Kidney Dis… · Tests: 68-Gallium-DOTATATE-PET/CT Study of Anlotinib Hydrochloride Capsules in the Treatment of Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma NCT05994365n/a3 sites📍 Beijing📍 Tianjin📍 Tianjin Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Tests: Anlotinib Hydrochloride Capsule Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors NCT04119024Phase 13 sites📍 Duarte📍 Los Angeles📍 Stanford Anusha Kalbasi · Tests: Biopsy, Biospecimen Collection, Computed Tomography, Cyclophosphamide, Fludarabine Phosphate A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma NCT06860971Phase 335 sites📍 Hefei📍 Beijing📍 Chongqing Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Tests: AL2846 Capsules, AL2846 Placebo Pharmaceutical Management in Targeted Radioligand Therapy NCT07389512n/a3 sites📍 Bron📍 Dijon📍 Lille Hospices Civils de Lyon Targeted Therapy to Increase RAI Uptake in Metastatic DTC NCT05024929n/a9 sites📍 San Francisco📍 Atlanta📍 Boston Children's Hospital of Philadelphia · Tests: Whole body scan A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors NCT04913285Phase 148 sites📍 Los Angeles📍 Los Angeles📍 San Diego Pierre Fabre Medicament · Tests: KIN-2787, KIN-2787 and binimetinib The Value of 68Ga-FAPI PET/CT in Detecting Recurrent and Metastatic Lesions in Patients with Thyroid Cancer After Surgery NCT06800768n/a1 site📍 Shanghai Ruijin Hospital
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy